What the data says: Ozempic, the antidiabetic medication, has seen its projections go through the roof after it became a popular drug to take for weight loss. It is forecasted to reach more than $17B in sales by 2029 after registering around $9B in sales in 2022. The jump from last year to this year is projected to be a 23% increase to around $12.5B. Relevance: Ever since users realized that one of Ozempic's side effects was weight loss, its popularity grew so much that those with diabetes had trouble finding it. Berberine is a cheaper, natural alternative that some have dubbed "nature's Ozempic." It is a bright yellow compound that can be extracted from the stem, roots, and bark of a variety of plant species. It is available in the U.S. from many different manufacturers, leading some to choose it over trying to find Ozempic. Other projections: The studies about it causing weight loss are limited. But the berberine market is expected to grow exponentially over the next 10 years. In 2022, the berberine supplements market was estimated at $885M. It's expected to grow to $2.1B by 2033. |
